IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways

被引：0
作者：
Wenpeng Cai
Yongfang Ma
Li Song
Niandie Cao
Jiafeng Gao
Shuping Zhou
Xiaolong Tang
机构：
[1] Anhui University of Science and Technology,Medical school
[2] Anhui University of Science & Technology,Medical School
[3] Institute of Environment-friendly Materials and Occupational Health of Anhu University of Science and Technology (Wuhu),undefined
来源：
BMC Cancer | / 23卷
关键词：
Insulin-like growth factor-1; Insulin-like growth factor-1 receptor; Sorafenib; Hepatocellular carcinoma; PI3K / akt, RAS / raf / ERK; Podophyllotoxin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 152 条
  • [1] Zhang Y(2022)ASIC1a stimulates the resistance of human hepatocellular carcinoma by promoting EMT via the AKT/GSK3β/Snail pathway driven by TGFβ/Smad signals J Cell Mol Med 26 2777-92
  • [2] Cao N(2022)A pan-cancer analysis on the carcinogenic effect of human adenomatous polyposis coli PLoS ONE 17 e0265655-65
  • [3] Gao J(2017)Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy J Gastrointest Oncol 8 256-64
  • [4] Liang J(2021)LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells Int J Med Sci 18 1456-22
  • [5] Liang Y(2020)Targeted therapy for hepatocellular carcinoma Signal Transduct Target Ther 5 146-87
  • [6] Xie Y(2017)New knowledge of the mechanisms of sorafenib resistance in liver cancer Acta Pharmacol Sin 38 614-704
  • [7] Zhou S(2020)New insights from IGF-IR stimulating activity analyses: pathological considerations Cells 9 862-98
  • [8] Tang X(2021)Insulin-like growth Factor-1 (IGF-1) and its monitoring in Medical Diagnostic and in Sports Biomolecules 11 217-92
  • [9] Zhang Y(2018)Insulin-like growth factor (IGF) system in Liver Diseases Int J Mol Sci 19 1308-52
  • [10] Liu X(2020)IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis Dev Biol 463 77-66
12345678910